His primary scientific interests are in Magnetic resonance imaging, Fatty liver, Radiology, Nonalcoholic fatty liver disease and Internal medicine. The various areas that Claude B. Sirlin examines in his Magnetic resonance imaging study include Biopsy, Pathology, Nuclear medicine and Nuclear magnetic resonance. His Fatty liver study integrates concerns from other disciplines, such as Steatosis, Liver biopsy, Chronic liver disease, Liver disease and In vivo magnetic resonance spectroscopy.
His Radiology research is multidisciplinary, incorporating elements of Differential diagnosis, Hepatocellular carcinoma, Liver fibrosis and Surgery. His studies deal with areas such as Overweight, Steatohepatitis and Fatty acid as well as Nonalcoholic fatty liver disease. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Endocrinology.
His primary areas of investigation include Radiology, Internal medicine, Magnetic resonance imaging, Nonalcoholic fatty liver disease and Gastroenterology. The study incorporates disciplines such as Hepatocellular carcinoma and Cirrhosis in addition to Radiology. His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology.
Claude B. Sirlin combines subjects such as Biopsy, Pathology, Nuclear medicine and Nuclear magnetic resonance with his study of Magnetic resonance imaging. In his research, Receiver operating characteristic is intimately related to Liver biopsy, which falls under the overarching field of Nonalcoholic fatty liver disease. Claude B. Sirlin has researched Gastroenterology in several fields, including Placebo, Prospective cohort study and Steatohepatitis.
His main research concerns Internal medicine, Radiology, Magnetic resonance imaging, Nonalcoholic fatty liver disease and Hepatocellular carcinoma. His Internal medicine study frequently links to adjacent areas such as Gastroenterology. His work deals with themes such as Chronic liver disease and Stage, which intersect with Radiology.
His Magnetic resonance imaging research incorporates elements of Liver disease, Clinical trial, Retrospective cohort study and Confidence interval. His Nonalcoholic fatty liver disease research includes themes of Body mass index, Steatosis, Quantitative ultrasound and Nuclear medicine. His Hepatocellular carcinoma research integrates issues from Malignancy, MEDLINE, Cirrhosis, Medical physics and Carcinoma.
Internal medicine, Nonalcoholic fatty liver disease, Radiology, Gastroenterology and Hepatocellular carcinoma are his primary areas of study. His study brings together the fields of Magnetic resonance imaging and Internal medicine. His studies in Nonalcoholic fatty liver disease integrate themes in fields like Body mass index, Steatosis, Nuclear medicine and Stage.
His study in the fields of Liver imaging and Ultrasound under the domain of Radiology overlaps with other disciplines such as In patient. His research in Gastroenterology intersects with topics in Fibrosis, Placebo, Steatohepatitis and Risk factor. His Hepatocellular carcinoma research incorporates themes from Carcinoma and General surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ru-, Rh-, and Pd-Catalyzed C-C Bond Formation Involving C-H Activation and Addition on Unsaturated Substrates: Reactions and Mechanistic Aspects
Vincent Ritleng;Claude Sirlin;Michel Pfeffer.
Chemical Reviews (2002)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach;Laura M. Kulik;Richard S. Finn;Claude B. Sirlin.
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero;Laura M Kulik;Claude B. Sirlin;Andrew X. Zhu.
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
Scott B. Reeder;Irene Cruite;Gavin Hamilton;Claude B. Sirlin.
Journal of Magnetic Resonance Imaging (2011)
Decoding global gene expression programs in liver cancer by noninvasive imaging
Eran Segal;Claude B Sirlin;Clara Ooi;Adam S Adler.
Nature Biotechnology (2007)
In vivo characterization of the liver fat 1H MR spectrum
Gavin Hamilton;Takeshi Yokoo;Mark Bydder;Irene Cruite.
NMR in Biomedicine (2011)
Heritability of Nonalcoholic Fatty Liver Disease
Jeffrey B. Schwimmer;Jeffrey B. Schwimmer;Manuel A. Celedon;Joel E. Lavine;Joel E. Lavine;Rany Salem.
Nonalcoholic fatty liver disease
Elizabeth M. Brunt;Vincent W.-S. Wong;Valerio Nobili;Christopher P. Day.
Nature Reviews Disease Primers (2015)
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
Charlie C. Park;Phirum Nguyen;Carolyn Hernandez;Ricki Bettencourt.
Fatty Liver: Imaging Patterns and Pitfalls
Okka W Hamer;Diego A Aguirre;Giovanna Casola;Joel E Lavine.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: